Framing Messages for Smoking Cessation With Bupropion - 6

NACompletedINTERVENTIONAL
Enrollment

252

Participants

Timeline

Start Date

September 30, 2000

Primary Completion Date

September 30, 2004

Study Completion Date

December 31, 2006

Conditions
Tobacco Use Disorder
Interventions
DRUG

Bupropion

BEHAVIORAL

Smoking Abstinence Program

This investigation was a randomized controlled study of two framed message conditions for smoking cessation in combination with open label bupropion SR (300 mg/day). Two hundred fifty-eight cigarette smokers were randomly assigned to receive either gain- or loss-framed video and printed messages encouraging smoking abstinence. Preproduced video and printed information were chosen as the intervention media because of their reliability in delivering specific framed messages. All participants were seen at a community mental health center for 6 months and received a 7-week supply of bupropion SR.

Trial Locations (1)

06519

Substance Abuse Treatment Unit, New Haven

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER

NCT00104598 - Framing Messages for Smoking Cessation With Bupropion - 6 | Biotech Hunter | Biotech Hunter